APA (7th ed.) Citation

Ghiringhelli, F., & Rébé, C. (2024). Using immunogenic cell death to improve anticancer efficacy of immune checkpoint inhibitors: From basic science to clinical application. Immunological Reviews, 321(1), 335. https://doi.org/10.1111/imr.13263

Chicago Style (17th ed.) Citation

Ghiringhelli, François, and Cédric Rébé. "Using Immunogenic Cell Death to Improve Anticancer Efficacy of Immune Checkpoint Inhibitors: From Basic Science to Clinical Application." Immunological Reviews 321, no. 1 (2024): 335. https://doi.org/10.1111/imr.13263.

MLA (9th ed.) Citation

Ghiringhelli, François, and Cédric Rébé. "Using Immunogenic Cell Death to Improve Anticancer Efficacy of Immune Checkpoint Inhibitors: From Basic Science to Clinical Application." Immunological Reviews, vol. 321, no. 1, 2024, p. 335, https://doi.org/10.1111/imr.13263.